A case of advanced pancreatic neuroendocrine tumor in which octreotide long-acting repeatable was effective after failure of everolimus and sunitinib.

Kitade, Hironori; Ohtsubo, Koushiro; Hokkoku, Kengo; Mori, Mitsue; Osamura, Robert Yoshiyuki; Sakuma, Hiroshi; Nakai, Masuo; Yano, Seiji

Kitade, Hironori; Ohtsubo, Koushiro; Hokkoku, Kengo; Mori, Mitsue; Osamura, Robert Yoshiyuki; Sakuma, Hiroshi; Nakai, Masuo; Yano, Seiji.

Afiliação

Kitade H; Department of Pharmacy, Houju Memorial Hospital, 11-71, Midorigaoka, Nomi, Ishikawa 923-1226 Japan.
Ohtsubo K; 4Division of Medical Oncology, Cancer Research Institute, Kanazawa University, 13-1 Takara-machi, Kanazawa, Ishikawa 920-0934 Japan.
Hokkoku K; Department of Pharmacy, Houju Memorial Hospital, 11-71, Midorigaoka, Nomi, Ishikawa 923-1226 Japan.
Mori M; Department of Pharmacy, Houju Memorial Hospital, 11-71, Midorigaoka, Nomi, Ishikawa 923-1226 Japan.
Osamura RY; 5Department of Pathology, International University of Health and Welfare Mita Hospital, 1-4-3 Mita, Minato-ku, Tokyo, 108-8239 Japan.
Sakuma H; Department of Surgery, Houju Memorial Hospital, 11-71, Midorigaoka, Nomi, Ishikawa 923-1226 Japan.
Nakai M; Department of Surgery, Houju Memorial Hospital, 11-71, Midorigaoka, Nomi, Ishikawa 923-1226 Japan.
Yano S; Outpatient Cancer Chemotherapy Center, Houju Memorial Hospital, 11-71, Midorigaoka, Nomi, Ishikawa 923-1226 Japan.

Int Cancer Conf J ; 8(1): 24-28, 2019 Jan.

Article em En | MEDLINE | ID: mdl-31149542

Palavras-chave

Octreotide; Pancreatic neuroendocrine tumor; Somatostatin receptor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Int Cancer Conf J Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google